Malin Inghammar

lund university

H指数:24

被引数:1,716

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The risk of cardiovascular events following community-acquired sepsis: a nationwide cohort study in Sweden

社区获得性败血症后心血管事件的风险：一项在瑞典进行的全国性队列研究

Epidemiology & Infection

IF2.2

2026-03-100

OAAI

COVID-19 vaccination coverage and the effect on regional disparities in morbidity and mortality among older people in Sweden, 2021–2023

COVID-19疫苗接种覆盖率及其对瑞典老年人区域患病率和死亡率差异的影响，2021–2023

Scandinavian Journal of Public Health

IF2.1

2026-02-230

PRE

Oral fluoroquinolone use and the risk of aortic and mitral valve regurgitation: a nationwide cohort study

口服氟喹诺酮类药物使用与主动脉瓣和二尖瓣反流风险：一项全国性队列研究

BMJ Open

IF2.3

2026-02-100

Risk and prognosis of colorectal cancer following bacteraemia with Streptococcus bovis-Streptococcus equinus complex: A Swedish nationwide retrospective cohort study

Streptococcus bovis-Streptococcus equinus complex菌血症后结直肠癌的风险和预后：一项瑞典全国性回顾性队列研究

EPIDEMIOLOGY & INFECTION

IF2.2

2025-12-260

Vaccine protection against COVID-19 mortality in relation to time since last booster dose among nursing home residents in Sweden – A case-control study over 35 months

瑞典养老院居民中，与上次加强针接种时间相关的COVID-19死亡病例的疫苗保护效果——一项为期35个月的病例对照研究

Vaccine

IF3.5

2025-12-090

OAAI

Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines

社区获得性肺炎在免疫健全成人中的管理：瑞典指南更新版

Infectious Diseases

IF2.3

2025-08-200

Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial

吸入用多粘菌素B酶α（DNase I）治疗COVID-19重症呼吸衰竭：一项随机对照试验

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2025-04-240

Barriers and motivators associated with COVID-19 vaccination-a vaccine acceptance scoring system based on a population survey in southern Sweden

EUROPEAN JOURNAL OF PUBLIC HEALTH

IF3.9

2025-04-010

OAAI

Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination

INFECTIOUS DISEASES

IF2.3

2025-03-010

Immune evasiveness of SARS-CoV-2 variants and vaccine selection

LANCET INFECTIOUS DISEASES

IF31

2024-09-011

OAAI

Long-term Mortality and Hospital Readmissions Among Survivors of Sepsis in Sweden: A Population-Based Cohort Study

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2024-06-240

OAAI

Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months

接种疫苗和先前感染后18个月内对COVID-19-related死亡率的保护作用减弱

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2023-12-013

Influenza A subtype H3N2 is associated with an increased risk of hospital dissemination-an observational study over six influenza seasons

JOURNAL OF HOSPITAL INFECTION

IF3.1

2023-09-010

OAAI

A regression discontinuity analysis of the social distancing recommendations for older adults in Sweden during COVID-19

EUROPEAN JOURNAL OF PUBLIC HEALTH

IF3.9

2022-08-134

OAAI

Bacteraemia and infective endocarditis with Streptococcus bovis-Streptococcus equinus-complex: a retrospective cohort study

INFECTIOUS DISEASES

IF2.3

2022-06-225

A retrospective cohort study of the effect of SARS-CoV-2 point of care rapid RT-PCR at the Emergency Department on targeted admission

BMC INFECTIOUS DISEASES

IF3

2022-06-133

OAAI

COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA. 2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022

EUROSURVEILLANCE

IF7.8

2022-05-0536

OAAI

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities- surveillance results from southern Sweden, July 2021 to January 2022

EUROSURVEILLANCE

IF7.8

2022-03-0364

OAAI

Untitled Reply

CLINICAL INFECTIOUS DISEASES

IF7.3

2021-11-200

OAAI

Risk of environmental transmission of norovirus infection from prior room occupants

JOURNAL OF HOSPITAL INFECTION

IF3.1

2021-11-013

OAAI

Malin Inghammar

个人简介

教育背景

工作经历

荣誉奖项

研究方向